Chicoutimi, Canada Clinical Trials

A listing of Chicoutimi, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 79 clinical trials
Cognitive Impairment Registry

The purpose of this study is to develop a recruitment registry of potential drug study participants who may have amyloid, a specific biomarker for Alzheimer's disease, using a phone assessment of cognitive and behavioral functions. The investigator uses the responses to the phone questions to predict which participants most likely …

Accepts healthy volunteers
Online studies
amyloid
Online Study Center
(online study) Contact site
  • 978 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Web-Based Assessment Validation and Engagement Study

This study is looking for people who are over the age of 55 and have mild cognitive impairment or dementia. The study is also looking for people with normal cognition, as a comparison. The study is investigating a new computerized assessment.

Accepts healthy volunteers
cognitive impairment
Online studies
mild cognitive impairment
cognitive assessment
Online Study Center
(online study) Contact site
  • 1713 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Alzheimer's Disease Center Research Registry

This study is looking for people over the age of 55 who have normal cognition, memory problems, or mild dementia. The study is also looking for people who are care partners of someone who has dementia. The study is intended to match people with studies that may be a good …

Accepts healthy volunteers
Online studies
mild dementia
Online Study Center
(online study) Contact site
  • 386 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Promoting Reengagement in Daily Meaningful Activity Intervention for adults with mild cognitive impairment and their caregivers

The PRIMA project is design to help persons with mild cognitive impairment to help them to improve their engagement in personally meaningful activity and improve their overall quality of life with their family caregivers support. The goal of PRIMA project is to increase persons with mild cognitive impairment’s engagement in …

Accepts healthy volunteers
Online studies
Online Study Center
(online study) Contact site
  • 371 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Objective, Passive Assessment of LRRK2 Carriers (OPAL)

This study is currently only open to active participants in the University of Rochester’s VALOR-PD study. The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless …

movement disorder
Online studies
University of Rochester
(online study) Contact site
  • 64 views
  • 12 May, 2022
  • 1 location
  • Online study
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will either get semaglutide or a dummy medicine - which treatment participants get is decided by chance. Participants will need to …

Novo Nordisk Investigational Site
 (6.6 away) Contact site
  • 93 views
  • 11 Mar, 2022
  • +226 other locations
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ISIS 678354 Administered Subcutaneously to Patients With Severe Hypertriglyceridemia

The purpose of the study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.

Clinique des Maladies Lipidiques de Quebec Inc.
 (108.9 away) Contact site
  • 34 views
  • 17 Sep, 2022
  • +44 other locations
A Phase 3, Multinational, Randomized, Open-Label, Three Parallel-Arm Study of PF-06801591, an Anti-PD-1 Antibody, in Combination With Bacillus Calmette-Guerin (BCG Induction With or Without BCG Maintenance) Versus BCG (Induction and Maintenance) in Participants With High-Risk, BCG-Naïve Non-Muscle Invasive Bladder Cancer or PF-06801591 as a Single Agent in Participants With BCG-Unresponsive NMIBC (CREST)

The purpose of this study is to learn about the safety and effects of the study medicine (sasanlimab) in people with non-muscle invasive bladder cancer. This study is seeking participants whose bladder cancer is still in early stages, has not spread outside of the bladder, has been removed with surgery, …

Centre integre universitaire de sante et de services sociaux du Saguenay-Lac-Saint-Jean
 (6.5 away) Contact site
  • 93 views
  • 14 Sep, 2022
  • +166 other locations
Multicenter, Double-blind, Parallel-group, Randomized, 48 Weeks, Dose-ranging, Placebo-controlled Phase II Trial to Evaluate Efficacy, Safety and Tolerability of Multiple Subcutaneous (s.c.) Doses of BI 456906 in Patients With Non-alcoholic Steatohepatitis (NASH) and Fibrosis.

This study is open for men and women with a liver disease called nonalcoholic steatohepatitis (NASH) and liver fibrosis. The purpose of the study is to find out whether a medicine called BI 456906 helps patients with NASH and liver fibrosis. The study tests 3 different doses of BI 456906 …

NECCR PrimaCare Research, LLC
 (459.6 away) Contact site
  • 126 views
  • 15 Sep, 2022
  • +173 other locations
A Phase Ib/III Randomised Study of Capivasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer (CAPItello-292)

A Phase Ib/III Randomised Study of Capivasertib plus Palbociclib and Fulvestrant versus Placebo plus Palbociclib and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer (CAPItello-292).

Research Site
 (6.6 away) Contact site
  • 54 views
  • 17 Sep, 2022
  • +14 other locations